Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeuti (Q36222932)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeuti |
scientific article |
Statements
1 reference
Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeuti (English)
1 reference
Ka F To
1 reference
Charles Erlichman
1 reference
Winnie Yeo
1 reference
Hyun C Chung
1 reference
Stephen L Chan
1 reference
Ling Z Wang
1 reference
Robert Lim
1 reference
Joel Picus
1 reference
Michael Boyer
1 reference
Frankie K F Mo
1 reference
Jane Koh
1 reference
Sun Y Rha
1 reference
Edwin P Hui
1 reference
Hei C Jeung
1 reference
Jae K Roh
1 reference
Simon C H Yu
1 reference
Qian Tao
1 reference
Brigette B Ma
1 reference
Anthony W H Chan
1 reference
Joanna H M Tong
1 reference
Anthony T C Chan
1 reference
Boon C Goh
1 reference
1 reference
1 reference
Identifiers
1 reference